Patent details

EP3315131 Title: THERAPEUTIC AGENT FOR FIBROSIS

Basic Information

Publication number:
EP3315131
PCT Application Number:
JP2016068902
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168145134
PCT Publication Number:
WO2016208744
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
THERAPEUTIC AGENT FOR FIBROSIS
French Title of Invention:
AGENT THÉRAPEUTIQUE CONTRE LA FIBROSE
German Title of Invention:
THERAPEUTIKUM FÜR FIBROSE
SPC Number:

Dates

Filing date:
24/06/2016
Grant date:
14/09/2022
EP Publication Date:
02/05/2018
PCT Publication Date:
29/12/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/09/2022
EP B1 Publication Date:
14/09/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/06/2023
Expiration date:
24/06/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/09/2022
 
 

Name:
Taiho Pharmaceutical Co., Ltd.
Address:
1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444, Japan (JP)

Inventor

Name:
FUJIOKA, Akio
Address:
Japan (JP)

Priority

Priority Number:
2015127788
Priority Date:
25/06/2015
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 31/47; A61P 11/00; C07D 215/50;

Publication

European Patent Bulletin

Issue number:
202237
Publication date:
14/09/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages